Shionogi & Co., Ltd. SGIOF
Set alert
At close · Oct 30
- YTD
- +37.08%
- 1 year
- +15.13%
- Open
- 20.85
- Prev close
- 20.85
- Mkt cap
- 17.75B
- Vol
- 100
- Avg vol
- 32
- EPS
- 1.80
- P/E
- 11.58
More statistics
- Low
- 20.85
- High
- 20.85
- Earnings
- Oct 29, 2026
News
1 month ago defenseworld.net
Shionogi & Co., Ltd. (OTCMKTS:SGIOF) Shares Down 7.1% – Here’s What Happened
Shionogi and Co., Ltd. (OTCMKTS:SGIOF - Get Free Report) shares fell 7.1% on Friday. The company traded as low as $16.39 and last traded at $16.39. Approximately 269 shares changed hands during…
1 month ago businesswire.com
Shionogi to Showcase Advancements Across its Infectious Disease Portfolio at IDWeek 2026
FLORHAM PARK, N.J.--(BUSINESS WIRE)--Shionogi Inc., a New Jersey-based subsidiary of Shionogi & Co., Ltd., (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi, Ph.D.), will present…
2 months ago businesswire.com
Shionogi Announces U.S. Government Procurement of Fetroja® (cefiderocol) Through BARDA's Project BioShield to Support National Preparedness for Drug-Resistant Bacterial Threats
OSAKA, Japan--(BUSINESS WIRE)--Shionogi & Co., Ltd. (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi, Ph.D.; hereafter "Shionogi") announced that the Biomedical Advanced Research…
3 months ago zacks.com
Shionogi & Co., Ltd. Unsponsored ADR (SGIOY) to Report Q1 Results: Wall Street Expects Earnings Growth
Shionogi & Co. (SGIOY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
5 months ago businesswire.com
New England Journal of Medicine Publishes Shionogi Study Demonstrating Ensitrelvir Prevents COVID-19 Following Exposure
OSAKA, Japan--(BUSINESS WIRE)--Shionogi & Co., Ltd. (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi, PhD; hereinafter “Shionogi”) announced that results from its global,…
6 months ago businesswire.com
Shionogi Receives Contract with U.S. Government Through BARDA's Project BioShield to Enhance National Preparedness for Drug-Resistant Bacterial Threats
OSAKA, Japan--(BUSINESS WIRE)--Shionogi & Co., Ltd. (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi, Ph.D.; hereafter “Shionogi”) announced that Shionogi Inc., a New Jersey-based…
7 months ago businesswire.com
Shionogi Completes Acquisition of All Rights to RADICAVA (edaravone)
OSAKA, Japan--(BUSINESS WIRE)--Shionogi & Co., Ltd. (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi, Ph.D.; hereafter “Shionogi”) announced that we have completed the transfer of…
7 months ago businesswire.com
Shionogi Announces First Patients Enrolled in Global Phase 2 Clinical Trial in Adults with Late-Onset Pompe Disease
OSAKA, Japan--(BUSINESS WIRE)--Shionogi & Co., Ltd. (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi, Ph.D.; hereafter “Shionogi”) announced the first patients were enrolled in…
1 year ago seekingalpha.com
Shionogi & Co., Ltd. (SGIOY) Q1 2025 Earnings Call Transcript
Shionogi & Co., Ltd. (OTCPK:SGIOY) Q1 2025 Earnings Conference Call July 28, 2025 3:30 AM ET Company Participants John A.
1 year ago seekingalpha.com
Shionogi & Co., Ltd. (SGIOY) Q3 2024 Earnings Call Transcript
Shionogi & Co., Ltd. (OTCPK:SGIOY) Q3 2024 Earnings Conference Call January 31, 2025 3:30 AM ET Company Participants Yoshimasa Kyokawa - VP, Corporate Communications Masako Kudou - VP, Finance &…
2 years ago seekingalpha.com
Shionogi & Co., Ltd. (SGIOY) Q2 2024 Earnings Call Transcript
Shionogi & Co., Ltd. (OTCPK:SGIOY) Q2 2024 Earnings Call Transcript October 29, 2024 2:00 AM ET Company Participants Yoshimasa Kyokawa - Vice President, Corporate Communications Isao Teshirogi -…
2 years ago seekingalpha.com
Shionogi & Co., Ltd. (SGIOY) Q1 2024 Earnings Call Transcript
Shionogi & Co., Ltd. (OTCPK:SGIOY) Q1 2024 Earnings Conference Call July 29, 2024 4:00 AM ET Company Participants Yoshimasa Kyokawa - Vice President, Corporate Communications Masako Kudou - Vice…
3 years ago seekingalpha.com
Shionogi & Co., Ltd. (SGIOF) Q1 2023 Earnings Call Transcript
Shionogi & Co., Ltd. (OTCPK:SGIOF) Q1 2023 Earnings Conference Call July 31, 2023 5:15 AM ET Company Participants Yoshimasa Kyokawa - VP, Corporate Communications John Keller - Senior Executive…
3 years ago seekingalpha.com
Shionogi & Co., Ltd. (SGIOF) Q1 2023 Earnings Call Transcript
Shionogi & Co., Ltd. (OTCPK:SGIOF) Q1 2023 Earnings Conference Call May 10, 2023 10:00 PM ET Company Participants Yoshimasa Kyokawa - Investor Relations Isao Teshirogi - Chairman and CEO John Keller…
3 years ago seekingalpha.com
Shionogi: Likely The Last Viable COVID Play
Xocova is an approved-in-Japan COVID antiviral. Other COVID investments are causing valuations to fall as their opportunities subside.
-
6 years ago benzinga.com
Stocks That Hit 52-Week Highs On Friday
Stocks That Hit 52-Week Highs On Friday